glp-1 impact on food industry of Weight Loss Drugs Choices GLP-1s' direct and indirect impacts

Ensuring equitable access and strengthening health systems will be essential to prevent widening health disparities.AgendaCo-chairsDr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMAModeratorDr Gaya Manori Gamhewage, Director, Department of Communication, WHOWelcomingDr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMAPresentation:WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adultsDr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr

has lost about 3 kg since initiating orlistat 1 month ago, but he reports frequent diarrhea

A compact and user-friendly pre-filled pen device designed for subcutaneous medication delivery.

Understanding the biology, current research gaps, and personalized evalu

The GLP-1 arena is currently dominated by two giants, Novo Nordisk and Eli Lilly, forming a duopoly in this high-growth field

Discover how Bioma Probiotics supports weight loss, balances gut health, and helps women reduce bloating, boost energy, and improve digestion naturally